Blue Bird Corporation
Blue Bird Corporation (BLBD) Financial Performance & Income Statement Overview
Explore the financials of Blue Bird Corporation (BLBD), including yearly and quarterly data on income, cash flow, and balance sheets.
Blue Bird Corporation (BLBD) Income Statement & Financial Overview
Explore comprehensive income reports for Blue Bird Corporation BLBD, broken down by year and quarter.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $358.85M | $313.87M | $350.21M | $333.37M |
| Cost of Revenue | $288.00M | $253.56M | $290.61M | $264.01M |
| Gross Profit | $70.85M | $60.32M | $59.61M | $69.35M |
| Gross Profit Ratio | $0.20 | $0.19 | $0.17 | $0.21 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $37.14M | $27.27M | $34.03M | $29.63M |
| Operating Expenses | $37.14M | $27.27M | $34.03M | $29.63M |
| Total Costs & Expenses | $325.14M | $280.83M | $324.63M | $293.64M |
| Interest Income | $1.26M | $1.57M | $1.004M | $990000.00 |
| Interest Expense | $1.81M | $1.92M | $2.03M | $2.11M |
| Depreciation & Amortization | $0.00 | $3.86M | $3.91M | $3.66M |
| EBITDA | $33.71M | $41.38M | $32.01M | $41.65M |
| EBITDA Ratio | $0.09 | $0.13 | $0.09 | $0.12 |
| Operating Income | $33.71M | $33.04M | $25.58M | $39.73M |
| Operating Income Ratio | $0.09 | $0.11 | $0.07 | $0.12 |
| Other Income/Expenses (Net) | -$111000.00 | $2.57M | $499000.00 | -$3.85M |
| Income Before Tax | $33.60M | $35.61M | $26.08M | $35.88M |
| Income Before Tax Ratio | $0.09 | $0.11 | $0.07 | $0.11 |
| Income Tax Expense | -$9.13M | $8.69M | $6.58M | $9.94M |
| Net Income | $26.05M | $28.72M | $24.66M | $28.71M |
| Net Income Ratio | $0.07 | $0.09 | $0.07 | $0.09 |
| EPS | $0.82 | $0.89 | $0.76 | $0.89 |
| Diluted EPS | $0.79 | $0.86 | $0.73 | $0.85 |
| Weighted Avg Shares Outstanding | $31.92M | $32.23M | $32.37M | $32.31M |
| Weighted Avg Shares Outstanding (Diluted) | $32.89M | $33.36M | $33.73M | $33.65M |
Over the past four quarters, Blue Bird Corporation demonstrated steady revenue growth, increasing from $333.37M in Q3 2024 to $358.85M in Q2 2025. Operating income reached $33.71M in Q2 2025, maintaining a consistent 9% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $33.71M, reflecting operational efficiency. Net income dropped to $26.05M, with EPS at $0.82. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan